Lyonbiopôle life sciences (infectious diseases) competitiveness cluster
Lyonbiopôle is a global centre of excellence in vaccination and diagnosis and was accredited as a competitiveness cluster by the government in 2005. Its aim is to carry out research into infectious human and animal diseases on a global scale, from diagnosis and prevention to treatment, using original administration systems.
The purpose of this “integrated” approach is to create a “health defence system” for the benefit of populations worldwide.
Lyonbiopôle actors
The President of Lyonbiopôle is Philippe Archinard, Managing Director of Transgene and Scientific Director of Mérieux Alliance. It also comprises:
- major industrial leaders such as Biomerieux, Sanofi Pasteur, Mérial, Genzyme, Becton Dickinson, etc.
- SME’s such as PX Therapeutics, genOway, Alize Pharma, etc.
- actors from the academic and hospital worlds: Hospices civils de Lyon (HCL), the Centre national de la recherche scientifique (CNRS), the Institut national de la santé et de la recherche médicale (Inserm), the École normale supérieure (ENS sciences), the Commissariat à l'énergie atomique (CEA), the Université de Lyon, the Institut Pasteur, etc.
- local authorities: Greater Lyon, the Rhône-Alpes Region, the DRIRE Rhône-Alpes, etc.
The cluster is based on the Lyon-Grenoble axis, which symbolises a strong link between industrial biology, structural biology and micro-nanotechnologies.
The objective of Lyonbiopôle
To become one of the top 3 infectious disease clusters in the world
The ambition of Lyonbiopôle
To develop a collaborative health defence system to fight infectious diseases.
The cluster is designed to be a “factory” for multi-partner R&D* projects, as well as an interfacing and networking tool for industrial actors and academic researchers. Its ambition is to become a catalyst that stimulates innovation and the local economy by:
- meeting public health needs
- strengthening the competitiveness of businesses
*Research and Development
Lyonbiopôle actions
- Regular R&D project creation.
- Creation of Lyon BiovAdvisor (LBA), a range of services dedicated to companies in the sector.
- Research and training support, particularly through its project to create a specialist infectious disease centre at the heart of the new Charles Mérieux Campus in Gerland (support for this dedicated property project).
- Support promoting and increasing the international profile of the biotechnologies cluster: continuation and expansion of Biovision, the number 1 international health forum.
Lyonbiopôle and Greater Lyon
Since the cluster was created, Greater Lyon has:
- supported 9 projects *
- provided more than €5.7 million in funding *
* between 2006 and 2008
- An industrial sector that is a net job creator in France and in Rhône-Alpes
- A sector that generates significant levels of investment
- A number of major public and private R&D* centres
- A sector based around the Charles Mérieux Campus construction project in Gerland
*Research and Development
Related files
Contacts
- Clémence Labat
Urban community of Lyon - DGDEI
life sciences director - Yves Laurent
Lyonbiopôle
deputy director
Related items
Website
